Condition
Acute Rejection (AR) of Transplanted Kidney clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Acute Rejection (AR) of Transplanted Kidney clinical trials that are recruiting, at sites in 2 countries (most in Slovakia (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Daratumumab for late antibody-mediated rejection in kidney transplant recipients with new donor-specific antibodies
This research tests whether daratumumab can help kidney transplant recipients who develop late antibody-mediated rejection after forming new donor-specific antibodies.
-
Monitoring kidney transplant recipients for rejection and damage
This study is trying to find better ways to monitor kidney transplant patients for signs of rejection and damage by collecting blood, urine, and biopsy samples.
Related topics
Quick answers
How many Acute Rejection (AR) of Transplanted Kidney clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Slovakia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.